Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Therapeutic Effects of Edaravone on Azoospermia: Free Radical Scavenging and Autophagy Modulation in Testicular Tissue of Mice

Authors
1 Mens Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Islamic Azad University Science and Research Branch, Tehran, Iran
2 Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Anatomical Sciences & Cognitive Neuroscience, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
Abstract
Background: Chemotherapeutic agents such as cyclophosphamide and busulfan have been shown to have a negative impact on the spermatogenesis process. Based on this fact, the objective of this study was to investigate the effects of edaravone on spermatogenesis in busulfan-induced mice. Methods: Forty adult male mice were equally divided into the four groups: 1) control, 2) edaravone, 3) busulfan, and 4) busulfan + edaravone. Then, the sperm parameters, histopathological examinations, and serum levels of testosterone, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were also assessed. Caspase-3, Beclin-1, and ATG-7 mRNA levels were also determined using real-time PCR. Results: Our results revealed that treatment of mice with edaravone in busulfan-induced azoospermia significantly improves sperm parameters, including total count, morphology, and viability (p<0.05). Furthermore, edaravone administration led to a significant increase in serum testosterone (p<0.0001) and FSH (p<0.001) levels, as well as testis weight (p<0.05) and volume (p<0.01). Edaravone also prevented a decrease in the number of testicular cells including spermatogonia (p<0.0001), primary spermatocytes (p< 0.001), round spermatids (p<0.0001), Sertoli (p<0.01), and Leydig cells (p<0.0001) in busulfan-treated mice. Additionally, in busulfan-induced azoospermia, edaravone significantly reduced the percentage of sperm with immature chromatin (p<0.0001). Following treatment with edaravone, a decrease in reactive oxygen species (ROS) and an increase in glutathione (GSH) production were noted compared to busulfan-treated mice. Further-more, caspase-3 (p<0.05), Beclin-1, and ATG-7 (p<0.001) genes expression decreased significantly in treatment groups compared to busulfan-induced azoospermia. Conclusion: According to our findings, edaravone can improve spermatogenesis in busulfan-induced azoospermia through free radical scavenging and autophagy modulation in testicular tissue.
Keywords

Ziaeipour S, Rezaei F, Piryaei A, Abdi S, Moradi A, Ghasemi A, et al. Hyperthermia versus busulfan: Finding the effective method in animal model of azoospermia induction. Andrologia. 2019;51(11): e13438.
Panahi S, Karamian A, Sajadi E, Aliaghaei A, Na-zarian H, Abdi S, et al. Sertoli cell–conditioned medium restores spermatogenesis in azoospermic mouse testis. Cell Tissue Res. 2020;379(3):577-87.
Caroppo E, Colpi GM. Hormonal treatment of men with nonobstructive azoospermia: what does the evidence suggest? J Clin Med. 2021;10(3):387.
Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and treat-ment of infertility in men: AUA/ASRM guideline part II. Fertil Steril. 2021;115(1):62-9.
Zhang HL, Zhao LM, Mao JM, Liu DF, Tang WH, Lin HC, et al. Sperm retrieval rates and clinical out-comes for patients with different causes of azoosper-mia who undergo microdissection testicular sperm extraction-intracytoplasmic sperm injection. Asian J Androl. 2021;23(1):59-63.
Zhankina R, Baghban N, Askarov M, Saipiyeva D, Ibragimov A, Kadirova B, et al. Mesenchymal stro-mal/stem cells and their exosomes for restoration of spermatogenesis in non-obstructive azoospermia: a systemic review. Stem Cell Res Ther. 2021;12(1): 229.
Barati E, Nikzad H, Karimian M. Oxidative stress and male infertility: current knowledge of patho-physiology and role of antioxidant therapy in dis-ease management. Cell Mol Life Sci. 2020;77(1): 93-113.
Dutta S, Henkel R, Sengupta P, Agarwal A. Physiological role of ROS in sperm function. In: Parekattil SJ, Esteves SC, Agarwal A, editors. Male Infertility. Switzerland: Springer, Cham; 2020. p. 337-45.
Sanocka D, Kurpisz M. Reactive oxygen species and sperm cells. Reprod Biol Endocrinol. 2004;2:12.
Tanaka M. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuro-protective agent]. Nihon Yakurigaku Zasshi. 2002; 119(5):301-8. Japanese.
Ismail H, Shakkour Z, Tabet M, Abdelhady S, Kobaisi A, Abedi R, et al. Traumatic brain injury: Oxidative stress and novel anti-oxidants such as Mitoquinone and Edaravone. Antioxidants (Basel). 2020;9(10):943.
Chen H, Chen Y, Wang X, Yang J, Huang C. Edaravone attenuates myocyte apoptosis through the JAK2/STAT3 pathway in acute myocardial in-farction. Free Radic Res. 2020;54(5):351-9.
Kassab AA, Aboregela AM, Shalaby AM. Edara-vone attenuates lung injury in a hind limb ische-mia-reperfusion rat model: a histological, immuno-histochemical and biochemical study. Ann Anat. 2020;228:151433.
Ommati MM, Attari H, Siavashpour A, Shafaghat M, Azarpira N, Ghaffari H, et al. Mitigation of cholestasis-associated hepatic and renal injury by edaravone treatment: evaluation of its effects on oxidative stress and mitochondrial function. Liver Res. 2021;5(3):181-93.
Tsounapi P, Saito M, Dimitriadis F, Koukos S, Shimizu S, Satoh K, et al. Antioxidant treatment with edaravone or taurine ameliorates diabetes-in-duced testicular dysfunction in the rat. Mol Cell Biochem. 2012;369(1-2):195-204.
Zhao X, Zhang E, Ren X, Bai X, Wang D, Bai L, et al. Edaravone alleviates cell apoptosis and mito-chondrial injury in ischemia–reperfusion-induced kidney injury via the JAK/STAT pathway. Biol Res. 2020;53(1):28.
Wang B, Lin W. Edaravone protects against pan-creatic and intestinal injury after acute pancreatitis via nuclear factor-κB signaling in mice. Biol Pharm Bull. 2020;43(3):509-15.
Yalcin Comert HS, Imamoglu M, Ercin ME, Eksi E, Kandaz M, Alver A, et al. Effect of edaravone on lungs and small intestine in rats with induced radiotherapy. Indian J Exp Biol. 2021;59:162-7.
Zarei L, Sadrkhanlou R, Shahrooz R, Malekinejad H, Eilkhanizadeh B, Ahmadi A. Protective effects of vitamin E and Cornus mas fruit extract on methotrexate-induced cytotoxicity in sperms of adult mice. Vet Res Forum. 2014;5(1):21-7.
Fernández JL, Muriel L, Goyanes V, Segrelles E, Gosálvez J, Enciso M, et al. Simple determination of human sperm DNA fragmentation with an im-proved sperm chromatin dispersion test. Fertil Steril. 2005;84(4):833-42.
Ziaeipour S, Ahrabi B, Naserzadeh P, Aliaghaei A, Sajadi E, Abbaszadeh H-A, et al. Effects of sertoli cell transplantation on spermatogenesis in azoo-spermic mice. Cell Physiol Biochem. 2019;52(3): 421-34.
Ayoubi M, Naserzadeh P, Hashemi MT, Rostami MR, Tamjid E, Tavakoli MM, et al. Biochemical mechanisms of dose-dependent cytotoxicity and ROS-mediated apoptosis induced by lead sulfide/ graphene oxide quantum dots for potential bio-imaging applications. Sci Rep. 2017;7(1):12896.
Tamamura M, Saito M, Kinoshita Y, Shimizu S, Satoh I, Shomori K, et al. Protective effect of edaravone, a free‐radical scavenger, on ischa-emia‐reperfusion injury in the rat testis. BJU Int. 2010;105(6):870-6.
Homma T, Kobayashi S, Sato H, Fujii J. Edara-vone, a free radical scavenger, protects against fer-roptotic cell death in vitro. Exp Cell Res. 2019; 384(1):111592.
Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:4350965.
Sukmawan R, Yada T, Toyota E, Neishi Y, Kume T, Shinozaki Y, et al. Edaravone preserves coro-nary microvascular endothelial function after is-chemia/reperfusion on the beating canine heart in vivo. J Pharm Sci. 2007;104(4):341-8.
Ito K, Ozasa H, Horikawa S. Edaravone protects against lung injury induced by intestinal ische-mia/reperfusion in rat. Free Radic Biol Med. 2005; 38(3):369-74.
Hayashi C, Ito M, Ito R, Murakumo A, Yamamoto N, Hiramatsu N, et al. Effects of edaravone, a radical scavenger, on hepatocyte transplantation. J Hepatobiliary Pancreat Sci. 2014;21(12):919-24.
Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, et al. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res. 2004;1029(2):200-6.
Zhao ZY, Luan P, Huang SX, Xiao SH, Zhao J, Zhang B, et al. Edaravone Protects HT22 Neurons from H2O2-induced Apoptosis by Inhibiting the MAPK Signaling Pathway. CNS Neurosci Ther. 2013;19(3):163-9.
Li Y, Liu H, Zeng W, Wei J. Edaravone protects against hyperosmolarity-induced oxidative stress and apoptosis in primary human corneal epithelial cells. PLoS One. 2017;12(3):e0174437.
Shimazaki H, Watanabe K, Veeraveedu PT, Ha-rima M, Thandavarayan RA, Arozal W, et al. The antioxidant edaravone attenuates ER-stress-medi-ated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis. Free Radical Res. 2010; 44(9):1082-90.
Qiao J, Wu Y, Liu Y, Li X, Wu X, Liu N, et al. Busulfan triggers intrinsic mitochondrial-depend-ent platelet apoptosis independent of platelet ac-tivation. Biol Blood Marrow Transplant. 2016;22 (9):1565-72.
Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 2007;17(10):839-49.
Wirawan E, Lippens S, Vanden Berghe T, Roma-gnoli A, Fimia GM, Piacentini M, et al. Beclin1: a role in membrane dynamics and beyond. Auto-phagy. 2012;8(1):6-17.
Yin J, Zhou Z, Chen J, Wang Q, Tang P, Ding Q, et al. Edaravone inhibits autophagy after neuronal oxygen-glucose deprivation/recovery injury. Int J Neurosci. 2019;129(5):501-10.